NCT04737720View on ClinicalTrials.gov

Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT)

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

January 24, 2013

Primary Completion Date

December 12, 2013

Conditions
Familial LCAT Deficiency
Interventions
DRUG

Recombinant LCAT

iv infusion

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT04737720 - Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT) | Biotech Hunter | Biotech Hunter